Annual EBIT:
-$196.13M+$370.80M(+65.41%)Summary
- As of today, PTCT annual earnings before interest & taxes is -$196.13 million, with the most recent change of +$370.80 million (+65.41%) on December 31, 2024.
- During the last 3 years, PTCT annual EBIT has risen by +$236.19 million (+54.63%).
- PTCT annual EBIT is now -741.31% below its all-time high of $30.58 million, reached on December 31, 2011.
Performance
PTCT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$3.49M+$38.35M(+110.01%)Summary
- As of today, PTCT quarterly earnings before interest & taxes is $3.49 million, with the most recent change of +$38.35 million (+110.01%) on September 30, 2025.
- Over the past year, PTCT quarterly EBIT has increased by +$55.45 million (+106.71%).
- PTCT quarterly EBIT is now -99.64% below its all-time high of $969.50 million, reached on March 31, 2025.
Performance
PTCT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$922.26M+$55.45M(+6.40%)Summary
- As of today, PTCT TTM earnings before interest & taxes is $922.26 million, with the most recent change of +$55.45 million (+6.40%) on September 30, 2025.
- Over the past year, PTCT TTM EBIT has increased by +$1.05 billion (+821.89%).
- PTCT TTM EBIT is now at all-time high.
Performance
PTCT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
PTCT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +65.4% | +106.7% | +821.9% |
| 3Y3 Years | +54.6% | +104.8% | +345.2% |
| 5Y5 Years | +13.8% | +107.5% | +350.5% |
PTCT EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +65.4% | -99.6% | +102.2% | at high | +279.7% |
| 5Y | 5-Year | at high | +65.4% | -99.6% | +102.2% | at high | +279.7% |
| All-Time | All-Time | -741.3% | +65.4% | -99.6% | +102.1% | at high | +279.7% |
PTCT EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $3.49M(+110.0%) | $922.26M(+6.4%) |
| Jun 2025 | - | -$34.86M(-103.6%) | $866.81M(-0.2%) |
| Mar 2025 | - | $969.50M(+6208.6%) | $868.31M(+691.7%) |
| Dec 2024 | -$196.13M(+65.4%) | -$15.87M(+69.5%) | -$146.75M(-14.9%) |
| Sep 2024 | - | -$51.97M(-55.8%) | -$127.76M(+33.6%) |
| Jun 2024 | - | -$33.36M(+26.8%) | -$192.45M(+31.2%) |
| Mar 2024 | - | -$45.55M(-1560.0%) | -$279.74M(+19.9%) |
| Dec 2023 | -$566.93M(-14.2%) | $3.12M(+102.7%) | -$349.40M(+31.9%) |
| Sep 2023 | - | -$116.66M(+3.3%) | -$513.18M(-9.2%) |
| Jun 2023 | - | -$120.64M(-4.7%) | -$470.00M(-2.9%) |
| Mar 2023 | - | -$115.22M(+28.3%) | -$456.92M(-3.9%) |
| Dec 2022 | -$496.62M(-14.9%) | -$160.66M(-118.6%) | -$439.93M(-17.0%) |
| Sep 2022 | - | -$73.49M(+31.7%) | -$376.10M(+2.3%) |
| Jun 2022 | - | -$107.56M(-9.5%) | -$384.89M(-2.6%) |
| Mar 2022 | - | -$98.22M(-1.4%) | -$375.12M(-0.0%) |
| Dec 2021 | -$432.32M(-24.7%) | -$96.83M(-17.7%) | -$374.95M(-1.8%) |
| Sep 2021 | - | -$82.28M(+15.9%) | -$368.19M(-10.7%) |
| Jun 2021 | - | -$97.79M(+0.3%) | -$332.65M(+17.6%) |
| Mar 2021 | - | -$98.05M(-8.9%) | -$403.83M(-1.5%) |
| Dec 2020 | -$346.58M(-52.4%) | -$90.07M(-92.7%) | -$397.88M(-8.1%) |
| Sep 2020 | - | -$46.73M(+72.3%) | -$368.19M(+1.1%) |
| Jun 2020 | - | -$168.98M(-83.5%) | -$372.43M(-57.2%) |
| Mar 2020 | - | -$92.09M(-52.5%) | -$236.91M(-22.9%) |
| Dec 2019 | -$227.44M(-96.8%) | -$60.38M(-18.5%) | -$192.80M(-8.6%) |
| Sep 2019 | - | -$50.98M(-52.4%) | -$177.55M(-1.6%) |
| Jun 2019 | - | -$33.46M(+30.3%) | -$174.81M(-19.0%) |
| Mar 2019 | - | -$47.98M(-6.3%) | -$146.92M(-27.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$115.56M(-79.7%) | -$45.14M(+6.4%) | -$115.69M(-77.7%) |
| Sep 2018 | - | -$48.23M(-765.3%) | -$65.09M(-36.3%) |
| Jun 2018 | - | -$5.57M(+66.7%) | -$47.76M(+12.7%) |
| Mar 2018 | - | -$16.74M(-407.1%) | -$54.68M(+15.0%) |
| Dec 2017 | -$64.29M(+51.3%) | $5.45M(+117.6%) | -$64.29M(+32.1%) |
| Sep 2017 | - | -$30.89M(-147.2%) | -$94.74M(+1.2%) |
| Jun 2017 | - | -$12.50M(+52.6%) | -$95.91M(+19.7%) |
| Mar 2017 | - | -$26.36M(-5.5%) | -$119.42M(+7.9%) |
| Dec 2016 | -$132.06M(+21.0%) | -$24.99M(+22.1%) | -$129.61M(+15.2%) |
| Sep 2016 | - | -$32.06M(+11.0%) | -$152.82M(+6.2%) |
| Jun 2016 | - | -$36.01M(+1.5%) | -$162.99M(+1.6%) |
| Mar 2016 | - | -$36.54M(+24.2%) | -$165.60M(+0.9%) |
| Dec 2015 | -$167.13M(-68.1%) | -$48.20M(-14.1%) | -$167.13M(-10.6%) |
| Sep 2015 | - | -$42.23M(-9.3%) | -$151.16M(-10.7%) |
| Jun 2015 | - | -$38.63M(-1.5%) | -$136.53M(-10.8%) |
| Mar 2015 | - | -$38.07M(-18.1%) | -$123.27M(-24.0%) |
| Dec 2014 | -$99.41M(-119.0%) | -$32.23M(-16.8%) | -$99.41M(-16.6%) |
| Sep 2014 | - | -$27.60M(-8.8%) | -$85.27M(-37.7%) |
| Jun 2014 | - | -$25.37M(-78.5%) | -$61.95M(-21.4%) |
| Mar 2014 | - | -$14.21M(+21.4%) | -$51.03M(-12.4%) |
| Dec 2013 | -$45.40M(-69.3%) | -$18.09M(-323.2%) | -$45.40M(-66.3%) |
| Sep 2013 | - | -$4.28M(+70.4%) | -$27.30M(-18.6%) |
| Jun 2013 | - | -$14.45M(-68.5%) | -$23.03M(-168.5%) |
| Mar 2013 | - | -$8.58M(-37.9%) | -$8.58M(-37.9%) |
| Dec 2012 | -$26.81M(-187.7%) | - | - |
| Mar 2012 | - | -$6.22M | -$6.22M |
| Dec 2011 | $30.58M | - | - |
FAQ
- What is PTC Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. annual EBIT year-on-year change?
- What is PTC Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is PTC Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. TTM EBIT year-on-year change?
What is PTC Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of PTCT is -$196.13M
What is the all-time high annual EBIT for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high annual earnings before interest & taxes is $30.58M
What is PTC Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, PTCT annual earnings before interest & taxes has changed by +$370.80M (+65.41%)
What is PTC Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of PTCT is $3.49M
What is the all-time high quarterly EBIT for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $969.50M
What is PTC Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, PTCT quarterly earnings before interest & taxes has changed by +$55.45M (+106.71%)
What is PTC Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of PTCT is $922.26M
What is the all-time high TTM EBIT for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high TTM earnings before interest & taxes is $922.26M
What is PTC Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, PTCT TTM earnings before interest & taxes has changed by +$1.05B (+821.89%)